Cargando…
Osteoid cell-derived chemokines drive bone-metastatic prostate cancer
One of the greatest challenges in improving prostate cancer (PCa) survival is in designing new therapies to effectively target bone metastases. PCa regulation of the bone environment has been well characterized; however, bone-targeted therapies have little impact on patient survival, demonstrating a...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070788/ https://www.ncbi.nlm.nih.gov/pubmed/37025604 http://dx.doi.org/10.3389/fonc.2023.1100585 |